| Autor: |
Silva FD; Biotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN, CNEN/SP, Avenida Prof. Lineu Prestes, 2242, Cidade Universitária, São Paulo, 05508-000, Brazil., Oliveira JE; Biotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN, CNEN/SP, Avenida Prof. Lineu Prestes, 2242, Cidade Universitária, São Paulo, 05508-000, Brazil., Freire RP; Biotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN, CNEN/SP, Avenida Prof. Lineu Prestes, 2242, Cidade Universitária, São Paulo, 05508-000, Brazil., Suzuki MF; Biotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN, CNEN/SP, Avenida Prof. Lineu Prestes, 2242, Cidade Universitária, São Paulo, 05508-000, Brazil., Soares CR; Biotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN, CNEN/SP, Avenida Prof. Lineu Prestes, 2242, Cidade Universitária, São Paulo, 05508-000, Brazil., Bartolini P; Biotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN, CNEN/SP, Avenida Prof. Lineu Prestes, 2242, Cidade Universitária, São Paulo, 05508-000, Brazil. pbartoli@ipen.br. |
| Abstrakt: |
Prolactin (PRL) is a hormone produced by the pituitary gland with innumerable functions, such as lactation, reproduction, osmotic and immune regulation. The present work describes the synthesis of hPRL in human embryonic kidney (HEK293) cells, transiently transfected with the pcDNA-3.4-TOPO ® vector carrying the hPRL cDNA. A concentration of ~ 20 mg/L, including glycosylated (G-hPRL) and non-glycosylated (NG-hPRL) human prolactin, was obtained, with ~ 19% of G-hPRL, which is higher than that observed in CHO-derived hPRL (~ 10%) and falling within the wide range of 5-30% reported for pituitary-derived hPRL. N-Glycoprofiling analysis of G-hPRL provided: (i) identification of each N-glycan structure and relative intensity; (ii) average N-glycan mass; (iii) molecular mass of the whole glycoprotein and relative carbohydrate mass fraction; (iv) mass fraction of each monosaccharide. The data obtained were compared to pituitary- and CHO-derived G-hPRL. The whole MM of HEK-derived G-hPRL, determined via MALDI-TOF-MS, was 25,123 Da, which is 0.88% higher than pit- and 0.61% higher than CHO-derived G-hPRL. The main difference with the latter was due to sialylation, which was ~ sevenfold lower, but slightly higher than that observed in native G-hPRL. The "in vitro" bioactivity of HEK-G-hPRL was ~ fourfold lower than that of native G-hPRL, with which it had in common also the number of N-glycan structures. |
